There has to be something underlying all of this.
For eighteen years, a young woman named Lucia moved through the medical system carrying a constellation of mismatched diagnoses, each one a partial answer to a question no one had yet learned to ask correctly. It was not until whole genome sequencing at Cleveland Clinic's Undiagnosed Disease Clinic revealed a mutation in her PPP2R5D gene that the true name emerged: Jordan syndrome, a neurodevelopmental disorder so rare that fewer than five hundred people in the world share it. Her story is a quiet indictment of medicine's limits and a testament to what becomes possible when a parent refuses to stop asking why, and a system finally builds a room designed to listen.
- Lucia spent eighteen years accumulating diagnoses — epilepsy, lupus, ADHD, fibromyalgia — none of which explained the full picture of seizures, developmental delays, and daily suffering she endured.
- Her mother Lisa watched the medical file grow thicker each year while specialists failed to see the single thread connecting everything, leaving the family to invent their own workarounds just to get through childhood.
- A pivotal referral to Cleveland Clinic's Undiagnosed Disease Clinic — a facility built precisely for patients lost in diagnostic limbo — finally brought whole genome sequencing to bear on Lucia's case.
- Four weeks after submitting a genetic sample, Lucia had her answer: a PPP2R5D gene mutation confirming Jordan syndrome, one of fewer than five hundred known cases worldwide.
- The diagnosis unlocked targeted seizure treatment, a multidisciplinary care team, and entry into clinical trials — and for the first time, Lucia found a community of people who understood her experience from the inside.
Lucia Adarve was eighteen years old when she finally learned what had been shaping her entire life. For nearly two decades, she had moved through the medical system accumulating diagnoses — epilepsy, lupus, fibromyalgia, ADHD, dyslexia — each one promising explanation, none of them fitting. From birth, her body had sent signals no one could interpret: missed developmental milestones, unpredictable seizures, sensitivity to light and sound, and struggles with balance and communication that disrupted her schooling and her sense of self.
Her mother Lisa, a former Montessori teacher, watched the file grow thicker while her instinct hardened into certainty. "There has to be something underlying," she said. When schools couldn't accommodate Lucia, Lisa pulled her out in third grade and taught her at home, inventing adaptive solutions — knitting for fine motor skills, horseback riding for balance — while continuing to push a medical system that rarely pushed back with answers. Lucia, for her part, grew pessimistic. "I saw doctors as something I went to occasionally that didn't do anything," she said.
The turning point came in 2025, when a physician at Cincinnati Children's Hospital actually listened — and referred them to Cleveland Clinic's Undiagnosed Disease Clinic, a facility designed for patients trapped in what medicine calls a diagnostic odyssey. Using whole genome sequencing, the clinic found what years of specialists had missed: a mutation on Lucia's PPP2R5D gene. She had Jordan syndrome, a neurodevelopmental disorder affecting movement, speech, and cognition, with fewer than five hundred confirmed cases in the world.
The diagnosis arrived with complicated emotions. Lisa felt vindicated after years of being implicitly doubted. Lucia felt relief, then frustration. "It frustrated me that it took eighteen years to get an answer," she said. But the name opened real doors: reduced seizures through targeted medication, a coordinated care team, a clinical trial, and a community of other Jordan syndrome patients who understood her in ways no specialist ever had.
Now Lucia is pursuing a degree in criminal behavioral psychology — one of only a handful of Jordan syndrome patients living with relative independence, a fact she credits to her mother's refusal to accept silence as an answer. "She's getting back to who she was," Lisa said. "She's helping others, she's making friends." After eighteen years without a name, Lucia finally has one — and with it, the ground to stand on.
Lucia Adarve was eighteen years old when she finally learned what had been wrong with her all along. For nearly two decades, she had moved through the medical system like someone searching for a name in a crowded room—close enough to hear it called, never quite certain it was hers. She had accumulated diagnoses the way other teenagers accumulate friends: epilepsy, lupus, fibromyalgia, ADHD, dyslexia. Each label promised explanation. None of them fit.
From birth, Lucia's body had sent signals no one could read. She missed developmental milestones. Seizures came without warning, sometimes leaving her collapsed on the ground with concussions and injuries. Loud noises and bright lights sent her into distress. She struggled to balance, to communicate, to keep up in school. Her mother, Lisa, a former Montessori teacher, watched her daughter's medical file grow thicker each year, each new specialist adding another diagnosis to a stack that made no coherent sense. "There's no way this one child has all of these labels and issues," Lisa said. "There has to be something underlying." But no doctor seemed to hear her.
Lucia's childhood became a series of workarounds. When she couldn't keep up at multiple schools, Lisa pulled her out in third grade and taught her at home. She invented solutions: knitting to build fine motor skills, horseback riding to improve balance, a ladder in the backyard so Lucia could reach the woods where her siblings played. But adaptation could only go so far. Lucia experienced fainting spells that sometimes cracked her skull. She developed anemia. She grew pessimistic about doctors and treatments, finding more comfort in her service dog than in any specialist's office. "No one listened to me," she said. "I saw doctors as something I went to occasionally that didn't do anything."
The breakthrough came in 2025, when Lucia and her mother visited Dr. Todd Arthur at Cincinnati Children's Hospital. Arthur did something different: he listened. As they recounted pages of diagnoses and symptoms, he began researching in real time. He referred them to the Cleveland Clinic's Undiagnosed Disease Clinic, a facility designed specifically for patients trapped in what doctors call a diagnostic odyssey. For ultra-rare conditions, that odyssey typically lasts more than a decade. The clinic uses whole genome sequencing—a complete reading of a person's DNA—to find the answers that traditional medicine has missed.
Lucia provided a genetic sample. Four weeks later, the clinic called with a diagnosis: a mutation on her PPP2R5D gene. She had Jordan syndrome, a neurodevelopmental disorder so rare that fewer than five hundred confirmed cases exist worldwide. The condition affects movement, speech, reading, and writing. It can cause seizures, autism, and ADHD. As patients age, some develop movement problems similar to Parkinson's disease. Lucia had been living with it her entire life without a name.
The diagnosis changed everything and nothing at once. Lisa felt vindicated. "It finally felt like, wow, these things were real," she said. "I wasn't being overprotective. I knew something was different." Lucia's reaction was more complicated. "I felt really happy about it for a month or two," she said. "Then I started to feel slightly annoyed, because it frustrated me that it took eighteen years to get an answer." But the name opened doors. Medications reduced her seizures. A multidisciplinary team built a management plan. She connected with advocacy groups and support networks of other Jordan syndrome patients who understood her in ways doctors never had. She joined a clinical trial testing new treatments.
Now, at eighteen, Lucia is working toward a degree in criminal behavioral psychology. She is one of only a handful of Jordan syndrome patients able to function relatively independently—a fact she attributes entirely to her mother's refusal to accept that her daughter's suffering was simply the way things had to be. "I was extremely lucky to get my mom," Lucia said. "She's one of the best people I know." Lisa, watching her daughter reclaim pieces of herself, said Lucia was getting back to who she had always been underneath the undiagnosed pain. "She knows what she has, so she can kind of stand up and advocate for herself," Lisa said. "She's getting back to who she was. She's helping others, she's making friends."
Notable Quotes
No one listened to me. I didn't see doctors as a good thing. I saw them as something I went to occasionally that didn't do anything.— Lucia Adarve
It finally felt like, wow, these things were real. I wasn't being overprotective. I knew something was different.— Lisa Adarve, Lucia's mother
The Hearth Conversation Another angle on the story
What strikes you most about this story—is it the eighteen years, or something else?
It's the gap between what Lucia was experiencing and what anyone could name. She had real symptoms, real suffering, but no framework to understand them. That's a kind of invisibility that compounds itself.
Her mother seems to have been the crucial actor here. What would have happened without Lisa's persistence?
Lucia would likely still be cycling through specialists, accumulating more labels that don't stick. Lisa refused to accept that her daughter's symptoms were separate problems. She insisted there was an underlying cause. Most parents would have done the same, but most don't have the resources or the knowledge to push back against medical authority the way Lisa did.
The diagnosis itself—Jordan syndrome—is incredibly rare. Does naming it actually change Lucia's life, or is it mostly symbolic?
It's both. Symbolically, it validates eighteen years of real suffering. But practically, it opens access to targeted treatment, to communities of people who understand, to clinical trials. The seizure medication reduction alone is material. But yes, there's also something profound about finally having language for your own experience.
She said she felt "annoyed" that it took eighteen years. That's an interesting emotional response to getting answers.
It's honest. Relief and frustration aren't mutually exclusive. She lost eighteen years to a condition that could have been identified much earlier if the right technology and the right doctor had intersected with her case sooner. That's a legitimate loss, even if the diagnosis itself is good news.
What happens now? Is this an ending or a beginning?
It's a beginning. She's in a clinical trial. She's building a life. But it also points to a larger problem: how many other people are still in that eighteen-year gap, waiting for their own name?